Home GoLiver Therapeutics

GoLiver Therapeutics

GoLiver Therapeutics

GoLiver Therapeutics
Category
Business Description
GoLiver Therapeutics is a spin-off of Inserm and the University of Nantes (CRTI UMR1064, ITUN, Nantes University Hospital). The company specializes in the development of Innovative Therapy Drugs (IMT) to meet an urgent unmet medical need in transplantation. It aims to become a major leader in regenerative medicine by tackling liver regeneration to treat liver disease without transplantation using differentiated pluripotent stem cells, globally.
Based in
Nantes
Tags
Biotechnology, Health Care, Pharmaceutical
Total Funding
No funding announced yet
Founded
2017
Website
https://golivertx.com/
💡 You're a corporate or investor and looking for startups that are innovating in the same market as GoLiver Therapeutics? We're happy to assist you with our Startup Sourcing service.

ABOUT US

EU-Startups.com is the leading online magazine about startups in Europe. Learn more about us and our advertising options.

FOLLOW US

© Menlo Media S.L. - All rights reserved.